摘要
本文用随机方法对185名健康妇女放置含消炎痛VCu 200(含药组)和不含消炎痛的VCu 200(不含药组)作为受试者,在放器前、后进行月经血量(MBL)、血红蛋白浓度(Hb)的测定。结果表明,置器后半年内,不含药组平均月经血量比含药组明显增多(P<0.01);血红蛋白值比含药组明显下降(P<0.01);半年后两组MBL、Hb值均无明显差别(P>0.05)。含药组放器前及后1,2,3,6,9,12周期的自身MBL、Hb值与不含药组自身对照相比,后者MBL明显增加,第一周期最为明显,增加达73%,直至第9周期基本恢复到放器前水平(P>0.05)。不含药组Hb值放器后明显下降,尤以第1、2周期最为明显,均下降9.0%含药组放器后MBL值略增加,Hb值略下降,但各周期与放环前相比差别无显著性(P>0.05)。不含药组放器后月经过多(MBL>80ml)、Hb<12g的发生率较高,以放器后半年内最为显著。含药组月经过多、Hb<12g的发生率均和放器前相仿,差别无显著性。
Menstrual Blood Loss (MBL) and Heamoglobin (Hb) were measured at pre- and 1 st,
2 nd, 3 rd, 6 th, 9 th, and 12 th post-insertion cycle in 185 women wearing the medicated IUDs
(93 cases) and non-medicated IUDs (92 cases). The results demonstrated that the mean MBL
of nonmedicated IUDs group was higher than that of the medicated IUDs group within the
first 6 months of insertion (p<0.01). In the non-medicated IUDs group MBL of the
first cycle after insertion had increased by 73% over the pre-inserion cycle and in
the medicated IUDs group had increased by 10%. At the same time, MBL of the nonmedicated
IUDs group in 1 st, 2 nd, 3 rd, 6 th, and 9 th post-insertion cycle significantly increased as
compared with ehe pre-insertion cycle. The Hb of tht non-medicated IUDs group was sig-
nificantly lower than that of the medicated IUDs group (p<0.01). The Hb of non-medicated
IUDs group in the 1 st and 2 nd post-insertion cycle had decreased by 9.0% as Compared
with the preinsertion cycle. In the medicated IUDs group there was no statistically difference
of Hb before and after insertion (P>0.05). The incidence of menorrbea (MBL>80ml)
or anemia (Hb<12g) was high in the non-medicated IUDs group and low in medicated
IUDs group.
出处
《生殖与避孕》
CAS
CSCD
北大核心
1990年第4期20-25,共6页
Reproduction and Contraception
关键词
月经血量
血红蛋白
VCU200
Menstrual blood loss
Haemoglobin
IUD containing Indomethacin
